These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6222547)

  • 1. [Immunologic detection and in vitro activity of suppressor cells].
    Gattringer C; Huber H
    Wien Klin Wochenschr; 1983 Mar; 95(5):138-44. PubMed ID: 6222547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell subsets in patients with systemic lupus erythematosus.
    Kucharz EJ; Sierakowski SJ
    Med Interne; 1988; 26(3):227-33. PubMed ID: 2973120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T lymphocyte subsets and antilymphocyte antibodies in lupus nephritis.
    Patel R; Patel DR; Najera D
    Clin Nephrol; 1986 Aug; 26(2):83-6. PubMed ID: 2944680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro immune cell function in six cases of immunoproliferative small intestinal disease after long term remission.
    López-Botet M; Chantar C; Plaza A; Abreu L; Kreisler M; de Landázuri MO
    Clin Exp Immunol; 1983 Sep; 53(3):663-71. PubMed ID: 6225578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte subpopulations in multiple myeloma. Shift in the helper/suppressor cell relation].
    Ludwig H; Fritz E
    Acta Med Austriaca; 1982; 9(5-6):215-20. PubMed ID: 6219532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [OKT-8+ suppressor T-lymphocytes are increased in patients with stable multiple myeloma].
    Ludwig C; Hicks MJ; Pena D; Durie BG
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1451-4. PubMed ID: 6227989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular DNA content of T helper, T suppressor and B lymphocytes in SLE.
    Surányi P; Mátyus L; Sonkoly I; Szegedi G
    Clin Exp Immunol; 1984 Oct; 58(1):37-41. PubMed ID: 6236918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus.
    Frazer IH; Mackay IR
    Clin Exp Immunol; 1982 Oct; 50(1):107-14. PubMed ID: 6216997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte subset analysis and related immunological findings in acquired immunodeficiency disease syndrome (AIDS) and malignancies.
    Hersh EM; Mansell PW; Reuben JM; Rios A; Newell GR; Goldstein AL; Lynch K
    Diagn Immunol; 1983; 1(3):168-73. PubMed ID: 6238750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM; Golub SH
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.
    Lauria F; Foa R; Cavo M; Gobbi M; Raspadori D; Giubellino MC; Tazzari PL; Tura S
    Clin Exp Immunol; 1984 Jun; 56(3):653-8. PubMed ID: 6235070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of human antinuclear antibodies by D-penicillamine: activation of inducer helper T cells in the absence of irradiation sensitive suppressor T cells.
    Mach PS; Brouilhet H; Amor B
    Clin Exp Immunol; 1986 Feb; 63(2):408-13. PubMed ID: 2938856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma: ecto-5' nucleotidase deficiency of suppressor/cytotoxic (CD8) lymphocytes is a marker for the expansion of suppressor T cells.
    Massaia M; Dianzani U; Pioppo P; Sibilla E; Boccadoro M; Pileri A
    Clin Exp Immunol; 1987 Aug; 69(2):426-32. PubMed ID: 2820641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Gergely P
    J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.